<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1269121</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Rivera</surname>
<given-names>Juan Carlos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1498887"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Opazo</surname>
<given-names>Ma. Cecilia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/305518"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hern&#xe1;ndez-Armengol</surname>
<given-names>Rosario</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2325226"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#xc1;lvarez</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2285278"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mendoza-Le&#xf3;n</surname>
<given-names>Mar&#xed;a Jos&#xe9;</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1372587"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caama&#xf1;o</surname>
<given-names>Esteban</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2579670"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gatica</surname>
<given-names>Sebastian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2266784"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bohmwald</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/229758"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bueno</surname>
<given-names>Susan M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/404453"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonz&#xe1;lez</surname>
<given-names>Pablo A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/427054"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neunlist</surname>
<given-names>Michel</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3763"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boudin</surname>
<given-names>Helene</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2506752"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalergis</surname>
<given-names>Alexis M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/217683"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Riedel</surname>
<given-names>Claudia A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/492835"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratorio de Endocrino-inmunolog&#xed;a, Departamento de Ciencias Biol&#xf3;gicas, Facultad de Ciencias de la Vida, Universidad Andr&#xe9;s Bello</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Facultad de Medicina Veterinaria y Agronom&#xed;a, Instituto de Ciencias Naturales, Universidad de las Am&#xe9;ricas</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Instituto de Ciencias Biom&#xe9;dicas, Facultad de Ciencias de la Salud, Universidad Aut&#xf3;noma de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Universit&#xe9; de Nantes, Inserm, TENS, The Enteric Nervous System in Gut and Brain Disorders, IMAD</institution>, <addr-line>Nantes</addr-line>, <country>France</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Departamento de Endocrinolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Federico Gatto, San Martino Hospital (IRCCS), Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Irenice Coronado-Arr&#xe1;zola, Universidad Mayor de San Sim&#xf3;n, Bolivia</p>
<p>Carmen Cabanelas Pazos Moura, Federal University of Rio de Janeiro, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Claudia A. Riedel, <email xlink:href="mailto:claudia.riedel@unab.cl">claudia.riedel@unab.cl</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1269121</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Rivera, Opazo, Hern&#xe1;ndez-Armengol, &#xc1;lvarez, Mendoza-Le&#xf3;n, Caama&#xf1;o, Gatica, Bohmwald, Bueno, Gonz&#xe1;lez, Neunlist, Boudin, Kalergis and Riedel</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Rivera, Opazo, Hern&#xe1;ndez-Armengol, &#xc1;lvarez, Mendoza-Le&#xf3;n, Caama&#xf1;o, Gatica, Bohmwald, Bueno, Gonz&#xe1;lez, Neunlist, Boudin, Kalergis and Riedel</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Gestational hypothyroxinemia (HTX) is a condition that occurs frequently at the beginning of pregnancy, and it correlates with cognitive impairment, autism, and attentional deficit in the offspring. Evidence in animal models suggests that gestational HTX can increase the susceptibility of the offspring to develop strong inflammation in immune-mediated inflammatory diseases. Ulcerative colitis (UC) is a frequent inflammatory bowel disease with unknown causes. Therefore, the intensity of ulcerative colitis-like disorder (UCLD) and the cellular and molecular factors involved in proinflammatory or anti-inflammatory responses were analyzed in the offspring gestated in HTX (HTX-offspring) and compared with the offspring gestated in euthyroidism (Control-offspring).</p>
</sec>
<sec>
<title>Methods</title>
<p>Gestational HTX was induced by the administration of 2-mercapto-1-methylimidazole in drinking water to pregnant mice during E10&#x2013;E14. The HTX-offspring were induced with UCLD by the acute administration of dextran sodium sulfate (DSS). The score of UCLD symptomatology was registered every day, and colon histopathology, immune cells, and molecular factors involved in the inflammatory or anti-inflammatory response were analyzed on day 6 of DSS treatment.</p>
</sec>
<sec>
<title>Results</title>
<p>The HTX-offspring displayed earlier UCLD pathological symptoms compared with the Control-offspring. After 6 days of DSS treatment, the HTX-offspring almost doubled the score of the Control-offspring. The histopathological analyses of the colon samples showed signs of inflammation at the distal and medial colon for both the HTX-offspring and Control-offspring. However, significantly more inflammatory features were detected in the proximal colon of the HTX-offspring induced with UCLD compared with the Control-offspring induced with UCLD. Significantly reduced mRNA contents encoding for protective molecules like glutamate-cysteine ligase catalytic subunit (GCLC) and mucin-2 (MUC-2) were found in the colon of the HTX-offspring as compared with the Control-offspring. Higher percentages of Th17 lymphocytes were detected in the colon tissues of the HTX-offspring induced or not with UCLD as compared with the Control-offspring.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Gestational HTX accelerates the onset and increases the intensity of UCLD in the offspring. The low expression of MUC-2 and GCLC together with high levels of Th17 Lymphocytes in the colon tissue suggests that the HTX-offspring has molecular and cellular features that favor inflammation and tissue damage. These results are important evidence to be aware of the impact of gestational HTX as a risk factor for UCLD development in offspring.</p>
</sec>
</abstract>
<kwd-group>
<kwd>gestational hypothyroxinemia</kwd>
<kwd>ulcerative colitis</kwd>
<kwd>colon inflammation</kwd>
<kwd>immune cells</kwd>
<kwd>autoimmunity</kwd>
<kwd>radical oxygen species</kwd>
</kwd-group>
<contract-num rid="cn001">1191300</contract-num>
<contract-num rid="cn002">ICN2021_045</contract-num>
<contract-sponsor id="cn001">Agencia Nacional de Investigaci&#xf3;n y Desarrollo<named-content content-type="fundref-id">10.13039/501100020884</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Instituto Millenium<named-content content-type="fundref-id">10.13039/501100007397</named-content>
</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="74"/>
<page-count count="15"/>
<word-count count="7956"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Translational Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The maternal thyroid hormones (THs) 3,5,3&#x2032;-L-tri-iodothyronine (T<sub>3</sub>) and 3,5,3&#x2032;5&#x2032;-L-tetra-iodide-thyronine (T<sub>4</sub>) are essential for proper fetus development (<xref ref-type="bibr" rid="B1">1</xref>). Gestational hypothyroxinemia (HTX) clinically characterized by normal  maternal T<sub>3</sub> and thyroid-stimulating hormone (TSH) but low T<sub>4</sub> serum levels has irreversible consequences over fetus development (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). The prevalence of this condition fluctuates between 1.3% and 23.9% around the world (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The high frequency of gestational HTX is due to the maternal thyroid gland must increase TH production, especially during the first 20 weeks of pregnancy, to provide with THs to the mother and fetus (<xref ref-type="bibr" rid="B5">5</xref>). If maternal iodine intake is not enough for TH synthesis, the maternal thyroid gland can fail to produce THs, and the maternal biological system will compensate to keep normal T<sub>3</sub> levels by decreasing T<sub>4</sub> production and increasing T<sub>3</sub> synthesis from T<sub>4</sub> (<xref ref-type="bibr" rid="B6">6</xref>). Even though gestational HTX is harmless to the mother, several studies in humans have revealed that this condition can be detrimental to the offspring (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). It has been shown that the offspring gestated under HTX (HTX-offspring) increases the probability of developing attentional deficit disorder (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>), low IQ (<xref ref-type="bibr" rid="B18">18</xref>), and autism (<xref ref-type="bibr" rid="B19">19</xref>). In addition, studies in mice have shown that the consequences of gestational HTX in the offspring surpass the central nervous system (CNS), increasing their susceptibility to have a strong inflammatory response upon induction of experimental autoimmune encephalomyelitis (EAE) (<xref ref-type="bibr" rid="B20">20</xref>). EAE is an inducible mouse autoimmune disease widely used as a model of multiple sclerosis (MS) (<xref ref-type="bibr" rid="B20">20</xref>). The molecular mechanisms that enhanced inflammatory and immune responses in HTX-offspring induced to EAE were the reduced suppressive capacity displayed by their T regulatory (T<sub>reg</sub>) lymphocytes (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, it seems possible that the HTX-offspring can be more susceptible to suffering an enhanced autoimmune disease due to an imprint on T<sub>reg</sub> lymphocytes and/or other immune cells. We hypothesized that gestational HTX could program the offspring&#x2019;s immune system to develop more robust inflammatory responses against immune challenges. Recently, we reported that the HTX-offspring showed a significantly increased CD8<sup>+</sup> T lymphocyte response during human metapneumovirus (hMPV) infection (<xref ref-type="bibr" rid="B22">22</xref>). Moreover, gestational hypothyroidism increased the offspring&#x2019;s immune response during EAE (<xref ref-type="bibr" rid="B21">21</xref>) and against <italic>Streptococcus pneumoniae</italic> infection (<xref ref-type="bibr" rid="B8">8</xref>). It is also possible that gestational HTX could affect other types of cells or organs besides the immune system. Along these lines, there are molecules and factors that cells produce to protect themselves from oxidative damage, such as antioxidant enzymes like glutamate-cysteine ligase catalytic subunit (GCLC) (<xref ref-type="bibr" rid="B23">23</xref>), heme oxygenase-1 (HO-1) (<xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>), NADPH quinone oxidoreductase 1 (NQO1) (<xref ref-type="bibr" rid="B28">28</xref>), and mucin-2 (MUC-2) (<xref ref-type="bibr" rid="B29">29</xref>). Therefore, we propose that HTX-offspring will be more susceptible to suffering immune-mediated diseases. The basis for this enhanced susceptibility consists of alterations in the immune system and the expression of cell-protective molecules in HTX-offspring, which promote inflammatory tissue damage. To test this hypothesis, the HTX-offspring and the offspring gestated in euthyroidism (Control-offspring) were induced to develop an ulcerative colitis-like disorder (UCLD). Ulcerative colitis (UC) is an immune-mediated inflammatory disorder of the colon characterized by chronic and continual mucosal inflammation (<xref ref-type="bibr" rid="B30">30</xref>). UC belongs to a group of pathologies classified as inflammatory bowel diseases (IBD), most of which have an unknown etiology (<xref ref-type="bibr" rid="B31">31</xref>). Patients who suffer from UC present abdominal pain, diarrhea, the presence of blood in the feces, and psychological distress (<xref ref-type="bibr" rid="B30">30</xref>). T lymphocytes, such as Th17 and T<sub>reg</sub> lymphocytes, can contribute significantly to the pathogenesis of UC (<xref ref-type="bibr" rid="B32">32</xref>). In this study, UCLD was induced in the male HTX-offspring and the male Control-offspring by dextran sodium sulfate (DSS) administration for an acute period of 6 days (<xref ref-type="bibr" rid="B33">33</xref>). Pathophysiological scores were performed during UCLD induction. Histopathology of the colon was analyzed to determine whether gestational HTX can increase UCLD symptomatology offspring. To determine the mechanisms that could be affected in the HTX-offspring&#x2019;s immune cells, the populations and contents of molecules with protective or inflammatory functions were measured in the colon tissue of the HTX-offspring.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Animals</title>
<p>C57BL/6 were obtained from Jackson laboratory (Bar Harbor, ME, USA). Both breeders and the offspring were kept at the animal facility of Universidad Andres Bello. The mice were maintained with at 12-h light/dark cycle according to the Universidad Andr&#xe9;s Bello and Agencia Nacional de Investigaci&#xf3;n y Desarrollo (ANID) bioethics committee guidelines. All mice were supervised daily by a veterinarian.</p>
</sec>
<sec id="s2_2">
<title>Maternal hypothyroxinemia induction</title>
<p>To perform breeding, two females and one male were placed in a cage, and the presence of a copulatory plug determined the next day&#x2019;s pregnancy. That day was referred to as embryonic day 1 (E1). Then, each pregnant female was placed in a cage individually. Pregnant females were separated randomly into three groups: the first group, named Control, received tap drinking water during the whole pregnancy; the second group, named HTX, received 0.02% methimazole (MMI) (M8506, Sigma-Aldrich, St. Louis, MO, USA) in the tap drinking water from E10 to E14; and the third group, named as HTX+T4, received 0.02% of MMI in the tap drinking water and a daily subcutaneous injection of 25 &#x3bc;g/kg T<sub>4</sub> in PBS from E10 to E14. The bottles containing MMI and T<sub>4</sub> solution were prepared fresh every day and kept protected from light. Blood samples from the facial vein were obtained to analyze thyroid function at E14. tT<sub>4</sub> was determined by chemiluminescence in a certified veterinary laboratory (LQCE). tT<sub>3</sub> and TSH were assayed by ELISA (MBS704901, MyBioSource, San Diego, CA, USA). The offspring were weaned 30 days postnatal (P30) and separated by sex. Male offspring were used for UCLD induction at day P55 of age (weighing 18 to 25 g). The offspring was named after the mother treatment as the Control-offspring and the HTX-offspring. All mice were euthanized by isoflurane in 5% O<sub>2</sub> inhalation according to AVMA guidelines (<xref ref-type="bibr" rid="B34">34</xref>).</p>
</sec>
<sec id="s2_3">
<title>Induction and evaluation of ulcerative colitis-like disorder</title>
<p>UCLD was induced in male offspring both from Control and HTX by the administration of 2% DSS (42867, Sigma-Aldrich) in the drinking water for 6 days as previously described (<xref ref-type="bibr" rid="B35">35</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>). The pathological score of UCLD was assessed daily during the whole treatment with DSS by measuring body weight, disease activity index (DAI) score, and fecal occult blood test (FOBT) score (<xref ref-type="bibr" rid="B33">33</xref>). The DAI score calculation corresponds to a qualitative visual analysis of two parameters: 1) stool consistency and 2) the presence of blood at the anus. A number is assigned to score the intensity of these symptoms (please see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref> for the score characterization).</p>
</sec>
<sec id="s2_4">
<title>Histological analysis</title>
<p>Mice were euthanized on day 6 of UCLD induction, and the proximal, middle, and distal portions of the colon were obtained to analyze the histological signs of inflammation in these regions (<xref ref-type="bibr" rid="B38">38</xref>). For this purpose, tissues were fixed in 4% formaldehyde in PBS, embedded in paraffin, cut into 4&#x2013;5 &#x3bc;m cross-sections, and stained with hematoxylin (100267, Newpath, Chile) and eosin (861006, Sigma-Aldrich). The stained sections were analyzed to obtain the histopathological score described previously (<xref ref-type="bibr" rid="B39">39</xref>) (see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>). Per mice, three sections per portion of the colon were analyzed blindly under white-light microscopy (DM1000, Leica Microsystem, Germany).</p>
</sec>
<sec id="s2_5">
<title>RT-qPCR analysis</title>
<p>Mice were euthanized on day 6 of UCLD induction, and colon samples were frozen at &#x2212;80&#xb0;C in RNA<italic>later</italic>&#xae; (R0901, Sigma-Aldrich). The samples were thawed in ice and then homogenized to further extract total RNA by the TRIzol&#xae; method (15596026, Thermo Fisher, Waltham, MA, USA). Total RNA was treated with DNAse I, quantified as described (<xref ref-type="bibr" rid="B7">7</xref>), and stored at &#x2212;80&#xb0;C. cDNA synthesis was performed with 1 &#xb5;g of RNA using Affinity Script QPCR cDNA Synthesis Kit (600559, Agilent Technologies, Santa Clara, CA, USA) and oligo(dT) according to the manufacturer&#x2019;s instructions. The primers used for the relative expression of genes encoding oxidative stress enzymes are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>. qPCR reactions were performed using Brilliant II SYBR Green QPCR Master Mix (600828, Agilent Technologies) following the manufacturer&#x2019;s instructions, as described previously (<xref ref-type="bibr" rid="B7">7</xref>). Data were normalized against the housekeeping gene ribosomal protein S6 (<italic>RPS6</italic>) transcript. The data were analyzed using the 2<sup>&#x2212;&#x394;&#x394;CT</sup> method and expressed as a fold change in gene expression relative to control.</p>
</sec>
<sec id="s2_6">
<title>Flow cytometry analysis of colon immune cells</title>
<p>Mice from each experimental group were euthanized on day 6 of UCLD induction to obtain the colon to isolate the immune cells as previously described (<xref ref-type="bibr" rid="B40">40</xref>). Colon samples were dissected longitudinally, and feces were removed with cold PBS. The adipose tissue and Peyer patches were eliminated from the colon tissue. To eliminate epithelial cells, the minced colon tissue was incubated in Hank&#x2019;s balanced salt solution (HBSS) + 2 mM of EDTA for 20 min at 37&#xb0;C with constant agitation. Then, the solution was passed through a 70-&#x3bc;m cell strainer to separate cells from cellular debris (Bioscience Inc., San Diego, CA, USA). The obtained samples were digested with a solution of 1 mg/ml of collagenase VIII (C2139, Sigma-Aldrich), 1.25 mg/ml of collagenase D (11088858001, Sigma-Aldrich), 1 mg/ml of dispase (D4818, Sigma-Aldrich), and 20 &#x3bc;g/ml of DNase I (10104159001, Sigma-Aldrich) in HBSS&#x2013;10% fetal bovine serum (FBS, A4766801, Thermo Fisher) for 20 min at 37&#xb0;C with constant agitation (200 rpm). Cells were passed through a 70-&#x3bc;m cell strainer and centrifuged at 450&#xd7;<italic>g</italic> for 5 min at 4&#xb0;C, and the obtained pellet was resuspended in a PBS&#x2013;5% FBS solution for flow cytometry analysis (<xref ref-type="bibr" rid="B41">41</xref>). First, cell suspensions were immunolabeled for extracellular markers. For that, cell suspensions were incubated in PEB buffer (PBS pH 7.4, 0.5% BSA, 2 mM EDTA) with the following antibodies at a 0.2-mg/ml concentration: anti-CD45-Bv421 (clone X54-5/7.1; BioLegend, San Diego, CA, USA), anti-CD3-FITC (clone RM4-5; BioLegend), anti-CD4-APC (clone RM4-5; BioLegend), anti-CD8-PE (clone RM4-5; BioLegend), anti-B220-PerCP 5.5 (clone RM4-5; BioLegend), anti-CD25-PE-Cy7 (clone PC61.5; BD Biosciences Inc., San Diego, CA, USA), anti-CD8a-PE/Cy7 (clone 53-6.7; BioLegend), anti-IA/IE-FITC (clone RM4-5; BioLegend), anti-CD11c-PE (clone RM4-5; BioLegend), anti-CD11b-PE-Cy7 (clone X54-5/7.1; BioLegend), anti-LY6C-PerCP 5.5 (clone RM4-5; BioLegend), and anti-LY6G-APC (clone RM4-5; BioLegend) for 1 h at room temperature (RT) in darkness. Then, the cells were fixed in 1% formaldehyde in PBS at RT. Afterward, the cells were incubated with 5 ng/ml of phorbol myristate acetate (PMA, 79346 Sigma-Aldrich) and 500 ng/ml of ionomycin (I0634, Sigma-Aldrich) for 3 h at 37&#xb0;C. Next, the cells were immunolabeled for intracellular markers. For that, the cells were incubated in PEB buffer with the following antibodies: anti-Foxp3-PE (clone MF23-16s; BD Biosciences Inc.), anti-Ror&#x3b3;T-Bv421 (clone Q31-378; BD Biosciences Inc.), and anti-IL-17a-APC-Cy7 (clone JES5-16E3; BD Biosciences Inc.) antibodies overnight at 4&#xb0;C. Flow cytometry analysis was acquired using a FACSCanto II (BD Biosciences Inc.), and data were analyzed using FlowJo&#x2122; v10.8 Software (BD Life Sciences Inc.). Myeloid cells are shown as the percentage of neutrophils (CD11b<sup>+</sup>Ly6G<sup>+</sup>Ly6C<sup>&#x2212;</sup>), monocytes (CD11b<sup>+</sup>Ly6G<sup>&#x2212;</sup>Ly6C<sup>+</sup>), macrophages (CD11b<sup>+</sup>Ly6G<sup>&#x2212;</sup>Ly6C<sup>&#x2212;</sup>), and dendritic cells (DCs) (CD11b<sup>&#x2212;</sup>CD11c<sup>+</sup>MHCII<sup>+</sup>) with respect to CD45<sup>+</sup>. The lymphoid cell population is presented as the percentage of B lymphocytes (CD3<sup>-</sup>B220<sup>+</sup>) and T cytotoxic (CD3<sup>+</sup>CD8<sup>+</sup>) concerning CD45. T regulatory cells (T<sub>reg</sub>) (CD25<sup>+</sup>Foxp3<sup>+</sup>) and Th17 cells (IL-17<sup>+</sup>Ror&#x3b3;T<sup>+</sup>) were calculated as the percentage of CD3<sup>+</sup>. The gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>4</bold>
</xref>.</p>
</sec>
<sec id="s2_7">
<title>Cytokine content from whole colon samples</title>
<p>The production of IL-17, IL-22, IFN-&#x3b3;, TNF-&#x3b1;, and IL-10 was determined by ELISA in total protein extracts from the whole colon of all experimental groups. Briefly, total protein extraction was performed as previously described (<xref ref-type="bibr" rid="B42">42</xref>) by mechanical homogenization in 1 ml of radioimmunoprecipitation assay buffer (RIPA) (20 mM of Tris&#x2013;HCl pH 7.5, 150 mM of NaCl, 1 mM of Na<sub>2</sub>EDTA, 1 mM of EGTA, 1% NP-40, 0.1% Triton X-100, 0.1% SDS) containing protease inhibitors (1 mM of PMSF, 0.1 mM of NaF, 200 mM of Na<sub>3</sub>VO<sub>4</sub>, 1 mM of leupeptin). Tissue homogenates were kept for 20 min on ice and then centrifuged at 18,000&#xd7;<italic>g</italic> for 10 min. The supernatants were stored at &#x2212;80&#xb0;C until analysis. Total protein concentration was determined by the Pierce BCA protein assay kit (23221, Thermo Scientific) according to the manufacturer&#x2019;s instructions. The contents of IL-17A (ELISA kit, 432501, BioLegend), IL-22 (436304, BioLegend), IFN-&#x3b3; (430801, BioLegend), TNF-&#x3b1; (430901, BioLegend), and IL-10 (431411, BioLegend) were measured in 100 &#x3bc;g of total protein of colon samples according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2_8">
<title>Statistical analyses</title>
<p>Statistical analyses were performed using Prism software 9.1.0 (GraphPad Software, Inc., San Diego, CA, USA). Results are shown as mean &#xb1; SEM. Statistical differences for THs and TSH were tested using the Welch <italic>t</italic>-test. Multiple comparisons were performed using one-way ANOVA or two-way ANOVA, followed by Turkey&#x2019;s <italic>post-hoc</italic> test or Kruskal&#x2013;Wallis analysis with Dunn&#x2019;s post-test for small samples. Statistical significance is indicated by <italic>p &lt;</italic>0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<p>Gestational HTX was induced in pregnant mice by the administration of 2% MMI in drinking water from day 10 to 14 of pregnancy (E10&#x2013;E14) (see <italic>Materials and methods</italic>), and the name of this experimental group is HTX. MMI is an inhibitor of thyroid peroxidase (TPO) the enzyme that synthesizes THs in the thyroid gland (<xref ref-type="bibr" rid="B43">43</xref>). It has been widely shown that the short administration of MMI during gestation produces transient HTX (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). To ensure that the UCLD symptoms in the offspring gestated in HTX (HTX-offspring) are due to T<sub>4</sub> reduction during pregnancy and not to a secondary effect of MMI. A second experimental group was included that reestablished T<sub>4</sub> levels during MMI treatment, and the name of this group is HTX+T4. To confirm that gestational HTX was induced in pregnant mice treated with MMI, tT<sub>4</sub>, tT<sub>3</sub>, and TSH were measured from the blood samples taken from all pregnant mice on day 14 of pregnancy. Thyroid hormones and TSH levels are plotted in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. The HTX group that received 2% MMI showed a reduction only in tT<sub>4</sub> and normal levels of tT<sub>3</sub> and TSH were observed in the serum (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A&#x2013;C</bold>
</xref>). Control and HTX+T4 pregnant mice showed similar levels of tT<sub>4</sub>, tT<sub>3</sub>, and TSH on day 14 of pregnancy. These results indicated that mice treated only with MMI suffered gestational HTX. For HTX+T4 that also received MMI and T<sub>4</sub>, the levels of T<sub>4</sub> were restored to normal levels.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Methimazole treatment in pregnant mice induces gestational hypothyroxinemia (HTX). The contents of tT<sub>4</sub>, tT<sub>3</sub>, and thyroid-stimulating hormone (TSH) were measured on day 14 of pregnancy (E14) in pregnant mice treated with tap drinking water (Control), MMI (HTX), or MMI and T<sub>4</sub> (HTX+T4) during E10&#x2013;E14. The contents of tT<sub>4</sub>, tT<sub>3</sub>, and TSH are plotted in <bold>(A&#x2013;C)</bold>, respectively. The values in the graphs are presented as mean &#xb1; SEM (Student&#x2019;s <italic>t</italic>-test). Statistical significance is indicated as **<italic>p</italic> &#x2264; 0.01 and ****<italic>p</italic> &lt; 0.0001. Pregnant dams: tT<sub>3</sub>: Ctrl <italic>N</italic> = 9, HTX <italic>N</italic> = 12, HTX+T4 <italic>N</italic> = 6. tT<sub>4</sub>: Ctrl <italic>N</italic> = 9, HTX <italic>N</italic> = 12, HTX+T4 <italic>N</italic> = 6. TSH: Ctrl <italic>N</italic> = 9, HTX <italic>N</italic> = 12, HTX+T4 <italic>N</italic> = 6.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g001.tif"/>
</fig>
<sec id="s3_1">
<title>UCLD symptoms are accelerated and enhanced in the male offspring gestated in HTX as compared with the offspring gestated under euthyroidism</title>
<p>The male progenies gestated in HTX, Control, and HTX+T4 were induced on postnatal day 55 (P55) with acute UCLD by the administration of 2% DSS in drinking water for 6 days (see <italic>Materials and methods</italic>). DSS is a sulfated polysaccharide widely used in animal models to induce UCLD (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B39">39</xref>). All experimental groups treated or not with DSS were monitored daily for 6 days. UCLD pathological scores were registered using the previously described scale (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B38">38</xref>). The symptoms of UCLD in the HTX-offspring started on day 3 of DSS administration (see black arrow in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>) as compared with the Control-offspring when symptoms appeared on day 5 after DSS treatment (see diamond arrow in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). The HTX-offspring showed significantly higher pathological scores on day 5 and day 6 after DSS administration as compared with the Control-offspring and on day 6 as compared with the HTX+T4-offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). As expected, all experimental groups not treated with DSS did not display pathological scores (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Weight loss was measured during 6 days after DSS treatment, and all experimental groups showed equivalent body weight loss during early time points of the experiments (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Only on day 5 of DSS treatment, the HTX-offspring showed a significant loss of weight as compared with the Control-offspring and on day 4 as compared with the HTX+T4-offspring. The FOBT was used to analyze the presence of blood in the feces (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). All experimental groups treated with DSS showed blood in the feces on day 4; however, it was significantly higher in the HTX-offspring on day 6 as compared with the Control-offspring and HTX+T4-offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Accelerated and enhanced pathological UCLD symptoms were observed in male HTX-offspring treated with 2% DSS for 6 days. Male HTX-offspring, Control-offspring, and HTX+T4-offspring were orally treated with 2% dextran sodium sulfate (DSS) for 6 days to induce acute ulcerative colitis-like disorder (UCLD). <bold>(A)</bold> The graph shows the analysis of the disease activity index (DAI). The arrow shows the early appearance of UCLD signs in the HTX-offspring. The diamond indicates the appearance of UCLD signs for the Control-offspring and HTX+T4-offspring. <bold>(B)</bold> The body weight percentage was registered daily for each experimental offspring induced or not with UCLD disease. <bold>(C)</bold> The presence of blood in the feces was determined by the fecal occult blood test (FOBT) analysis for each experimental group. The values are shown as mean &#xb1; SEM (two-way ANOVA and Tukey&#x2019;s post-test). Statistical significance is indicated as # for the Ctrl vs. the Ctrl+2% DSS group, &amp; the HTX vs. the HTX+2% DSS group, and * for the Ctrl+2% DSS vs. the HTX+2% DSS group when <italic>p</italic> &lt; 0.05. Ctrl <italic>N</italic> = 15, HTX <italic>N</italic> = 17, Ctrl+2%DSS <italic>N</italic> = 17, HTX+2%DSS <italic>N</italic> = 17, HTX+T4 <italic>N</italic> = 7, and HTX+T4 + 2%DSS <italic>N</italic> = 8.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Male HTX-offspring showed UCLD histopathological scores at the proximal, medial, and distal colon tissues</title>
<p>UC is characterized by histopathological signs of inflammation in the mucosa of the colon mainly at the distal and medial regions (<xref ref-type="bibr" rid="B38">38</xref>). Coronal sections of the proximal, middle, and distal colon from the HTX-offspring and Control-offspring induced or not with UCLD were stained with hematoxylin and eosin (see <italic>Materials and methods</italic>). Representative images for these sections of all experimental groups are shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. The average of the inflammatory scores for the proximal, middle, and distal colon is shown in <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B&#x2013;D</bold>
</xref>, respectively, and was calculated based on a scoring system summarized in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref> (<xref ref-type="bibr" rid="B40">40</xref>). The histopathological scores of the proximal, middle, and distal colon for the HTX-offspring and Control-offspring without UCLD induction were not zero (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B&#x2013;D</bold>
</xref> and see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>) because minimal cell infiltration was detected. This cell infiltration was greater for the HTX-offspring, and tissue distortion was also observed in this progeny. The HTX-offspring and Control-offspring induced with UCLD showed higher histopathological scores at the proximal, middle, and distal portions of the colon than the HTX-offspring and Control-offspring non-induced with UCLD. Some of these features were distortion of the tissue, erosions, and extensive inflammatory infiltration affecting different layers of the colon. In <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>, lymphatic nodules in the Control-offspring and HTX-offspring with UCLD were observed, showing that, in the HTX-offspring, the lymphatic nodule is bigger reaching the submucosa layer. Even though the histopathological scores of the middle and distal portions of the colon were not significantly different between the HTX-offspring and Control-offspring induced with UCLD (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>, respectively), the histopathological score for the proximal colon was significantly higher for the HTX-offspring with UCLD compared to the Control-offspring with UCLD (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Male HTX-offspring with UCLD has inflammation signs at the proximal, middle, and distal colon. The HTX-offspring and Control-offspring were orally treated with 2% DSS for 6 days to induce UCLD. On day 6, mice were euthanized, and the colon was isolated and stained with hematoxylin and eosin to perform histopathological analysis. <bold>(A)</bold> Images were taken from the proximal, middle, and distal colon of the HTX-offspring and Control-offspring induced or not with UCLD. A digital zoom of the mucosa appears to show signs of tissue damage. The arrow (&#x2192;) shows the inflammation area or lymphatic nodules, and the arrowhead (&#x27a4;) shows mucosa erosion. Histopathological score analyses of the proximal, middle, and distal colon regions were plotted in <bold>(B&#x2013;D)</bold>, respectively. The values in the graphs represent mean &#xb1; SEM (one-way ANOVA and Tukey&#x2019;s post-test). Statistical significance is indicated as *<italic>p</italic> &#x2264; 0.05, **<italic>p</italic> &#x2264; 0.01, *** <italic>p </italic>&lt; 0.001 and non significant (ns). <bold>(B)</bold> Ctrl <italic>N</italic> = 3, HTX <italic>N</italic> = 3, Ctrl+2%DSS <italic>N</italic> = 6, and HTX+2%DSS <italic>N</italic> = 6. <bold>(C)</bold> Ctrl <italic>N</italic> = 3, HTX <italic>N</italic> = 3, Ctrl+2%DSS <italic>N</italic> = 4, and HTX+2%DSS <italic>N</italic> = 6. <bold>(D)</bold> Ctrl <italic>N</italic> = 3, HTX <italic>N</italic> = 3, Ctrl+2%DSS <italic>N</italic> = 6, and HTX+2%DSS <italic>N</italic> = 6.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Lower content of GCLC and MUC-2 mRNA in the colon tissue from male HTX-offspring</title>
<p>Previous studies showed that oxidative stress increases during the inflammatory response of UC (<xref ref-type="bibr" rid="B46">46</xref>). Even though, the intestine counts with antioxidants and molecules that have protective roles to counteract inflammation, a reduced expression of these agents could contribute to the enhanced inflammatory UCLD (<xref ref-type="bibr" rid="B47">47</xref>). Therefore, mRNA relative expression encoding for antioxidant or oxidative stress proteins was measured in the colon of the HTX-offspring and Control-offspring with or without UCLD (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). The mRNA content of GCLC, the first rate-limiting enzyme of glutathione synthesis, was quantified in the colon samples for all experimental groups (<xref ref-type="bibr" rid="B23">23</xref>). Significantly lower levels of <italic>GCLC</italic> mRNA were found in the HTX-offspring as compared with the Control-offspring with or without UCLD induction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Interestingly, we observed an increase, although not significant, in the expression of <italic>GCLC</italic> in the colon samples from the Control-offspring induced with UCLD as compared with those not induced with UCLD. On the contrary, no increase of <italic>GCLC</italic> mRNA was detected in the HTX-offspring induced with UCLD as compared to mice in which UCLD was not induced. The mRNA content of MUC-2, an essential protein for normal intestinal barrier function, was measured in the colon samples derived from all experimental groups (<xref ref-type="bibr" rid="B29">29</xref>). The HTX-offspring not induced with UCLD showed a significantly lower expression of <italic>MUC-2</italic> mRNA levels as compared with the Control-offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). However, after UCLD induction, the Control-offspring showed reduced <italic>MUC-2</italic> mRNA levels equivalent to the HTX-offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). The observed reduction of <italic>MUC-2</italic> mRNA is consistent with the barrier damage reported for UC murine models (<xref ref-type="bibr" rid="B48">48</xref>). Lipocalin-2 is a bacteriostatic protein (<xref ref-type="bibr" rid="B49">49</xref>) whose expression has been shown to be increased in patients with active IBD (<xref ref-type="bibr" rid="B49">49</xref>) and in murine models for UC (<xref ref-type="bibr" rid="B50">50</xref>). An increase in <italic>Lipocalin-2</italic> expression was observed in both the Control-offspring and HTX-offspring suffering from UCLD, with no significant differences between these two experimental groups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). This result was consistent with previous observations in the murine model for UCLD (<xref ref-type="bibr" rid="B50">50</xref>). HO-1 is an enzyme that reduces inflammation and plays a modulatory role during intestinal inflammation (<xref ref-type="bibr" rid="B24">24</xref>). No differences were observed in the expression of <italic>HO-1</italic> mRNA between any experimental group (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). Even though there were no significant differences among these groups, there is a trend for reduced expression of <italic>HO-1</italic> mRNA in the HTX-offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). The expression of inducible nitric oxide synthetase (iNOS) has been reported to increase in UC patients (<xref ref-type="bibr" rid="B51">51</xref>). Given that iNOS synthesizes nitric oxide (NO), a high expression of this enzyme has been associated with tissue damage (<xref ref-type="bibr" rid="B52">52</xref>). A significant decrease in the relative expression of <italic>iNOS</italic> was found in the HTX-offspring suffering from UCLD when compared with the HTX-offspring without UCLD induction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>) and when compared with the Control-offspring with or without UCLD induction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). No significant differences were observed for the mRNA relative expression of <italic>NQO1</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>), <italic>Nrf2</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>), <italic>Gpx</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4H</bold>
</xref>), and <italic>catalase</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4I</bold>
</xref>) between the HTX-offspring and Control-offspring suffering from UCLD. A significant reduction in the levels of NQO1 mRNA of the HTX-offspring induced with UCLD compared with the HTX-offspring without UCLD induction and the Control-offspring without UCLD induction was found (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). The level of Nrf2 mRNA was also reduced in the HTX-offspring induced with UCLD as compared with the HTX-offspring without UCLD induction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>GCLC or MUC-2 mRNA levels were reduced in male HTX-offspring. The HTX-offspring and Control-offspring were orally treated with 2% dextran sodium sulfate (DSS) for 6 days to induce ulcerative colitis like disorder (UCLD). On day 6, mice were euthanized, and mRNA was isolated from the colon tissue to be analyzed by RT-qPCR. The mRNA levels were plotted as arbitrary units (a.u.) concerning the mRNA expression for the housekeeping gene <italic>RPS6</italic> used as a normalizer in the figures. <bold>(A)</bold> GCLC; <bold>(B)</bold> MUC-2; <bold>(C)</bold> Lipocalin-2; <bold>(D)</bold> HO-1; <bold>(E)</bold> iNOS; <bold>(F)</bold> NQO1; <bold>(G)</bold> NRF2; <bold>(H)</bold> Gpx; and <bold>(I)</bold> catalase. The values in the graphs are presented as mean &#xb1; SEM (Kruskal&#x2013;Wallis and Dunn&#x2019;s post-test). Statistical significance is indicated as *<italic>p</italic> &#x2264; 0.05, **<italic>p</italic> &#x2264; 0.01. <bold>(A)</bold> Ctrl <italic>N</italic> = 6, HTX <italic>N</italic> = 4, Ctrl+2%DSS <italic>N</italic> = 6, and HTX+2%DSS <italic>N</italic> = 7. <bold>(B)</bold> Ctrl <italic>N</italic> = 8, HTX <italic>N</italic> = 5, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 6. <bold>(C)</bold> Ctrl <italic>N</italic> = 11, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 7, and HTX+2%DSS <italic>N</italic> = 7. <bold>(D)</bold> Ctrl <italic>N</italic> = 8, HTX <italic>N</italic> = 5, Ctrl+2%DSS <italic>N</italic> = 6, and HTX+2%DSS <italic>N</italic> = 6. <bold>(E)</bold> Ctrl <italic>N</italic> = 9, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 4, and HTX+2%DSS <italic>N</italic> = 3. <bold>(F)</bold> Ctrl <italic>N</italic> = 9, HTX <italic>N</italic> = 9, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 3. <bold>(G)</bold> Ctrl <italic>N</italic> = 7, HTX <italic>N</italic> = 7, Ctrl+2%DSS <italic>N</italic> = 7, and HTX+2%DSS <italic>N</italic> = 6. <bold>(H)</bold> Ctrl <italic>N</italic> = 8, HTX <italic>N</italic> = 7, Ctrl+2%DSS <italic>N</italic> = 8, and HTX+2%DSS <italic>N</italic> = 6. <bold>(I)</bold> Ctrl <italic>N</italic> = 6, HTX <italic>N</italic> = 5, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 7.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>The population of Th17 lymphocytes is higher in the colon of male HTX-offspring with or without UCLD</title>
<p>The immune system plays a pivotal role in the development and outcome of UC pathology (<xref ref-type="bibr" rid="B53">53</xref>). Therefore, myeloid and lymphoid cell populations were quantified by flow cytometry from the colon of the HTX-offspring and Control-offspring without induction of UCLD and after 6 days of UCLD induction (<xref ref-type="bibr" rid="B47">47</xref>). Representative dot plots for neutrophils, monocytes, and macrophages are shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref> and that for DCs is shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>. The gating strategy is indicated in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>4</bold>
</xref>. The graphs of flow cytometry analyses of all experimental groups were plotted in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref> for neutrophils, in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref> for monocytes, and in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref> for macrophages. A similar percentage of neutrophils (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>), monocytes (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>), macrophages (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>), and DCs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>) was observed for all experimental offspring induced or not with UCLD. A subtle increase was observed in the Control-offspring and HTX-offspring suffering from UCLD as compared with the Control-offspring not induced with UCLD. Even though no significant differences were observed, some individuals gestated in HTX and not suffering from UCLD showed more neutrophils in the colon as compared with the Control-offspring with no UCLD. Flow cytometry analyses of various lymphocyte populations from the colon for each experimental group are shown in <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>. Representative dot-plots for CD4<sup>+</sup> T lymphocytes, CD8<sup>+</sup> T lymphocytes, B lymphocytes, Th17 lymphocytes, and T regulatory (T<sub>reg</sub>) lymphocytes are shown in <xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A&#x2013;E</bold>
</xref>, respectively. The percentage of CD4<sup>+</sup> T lymphocytes was similar among all offspring (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6F</bold>
</xref>). A significant increase of CD8<sup>+</sup> T lymphocytes was found in the HTX-offspring induced with UCLD as compared with the HTX-offspring not induced with UCLD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6G</bold>
</xref>). However, the percentage of CD8<sup>+</sup> T lymphocytes was similar between the HTX-offspring and the Control-offspring induced with UCLD. The percentage of B lymphocytes was similar among the four experimental groups induced or not with UCLD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6H</bold>
</xref>). The Th17 lymphocyte population was significantly increased in the colon of both HTX-offspring induced or not with UCLD compared with the Control-offspring induced or not with UCLD, respectively (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6I</bold>
</xref>). Not statistically significant differences were observed in any cytokine analyzed and between any experimental group. The T<sub>reg</sub> lymphocyte percentage was similar between all experimental groups induced or not with UCLD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6J</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The percentage of myeloid cells in the colon of male HTX-offspring was similar to the Control-offspring induced or not with UCLD. The HTX-offspring and Control-offspring were orally treated with 2% dextran sodium sulfate (DSS) for 8 days to induce ulcerative colitis-like disorder (UCLD). On day 6, mice were euthanized, and the colon was isolated to obtain immune cells that were incubated with specific antibodies to detect myeloid cells by flow cytometry analysis. <bold>(A)</bold> Representative dot-plots for neutrophils, monocytes, and macrophages are shown for each experimental group induced or not to develop UCLD. <bold>(B)</bold> Representative dot-plots for DC detection are shown for each experimental group induced to develop UCLD. The graphs with the percentage of neutrophils, monocytes, macrophages, and DCs for each experimental group are shown in <bold>(C&#x2013;F)</bold>, respectively. No significant differences between groups were observed. The values in the graphs are presented as mean &#xb1; SEM (Kruskal&#x2013;Wallis and Dunn&#x2019;s post-test). <bold>(C)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 7, Ctrl+2%DSS <italic>N</italic> = 9, and HTX+2%DSS <italic>N</italic> = 9. <bold>(D)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 8. <bold>(E)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 8, and HTX+2%DSS <italic>N</italic> = 8. <bold>(F)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 7.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g005.tif"/>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Increased percentage of Th17 lymphocytes in the colon of male HTX-offspring induced or not to develop UCLD. The HTX-offspring and Control-offspring were orally treated or not with 2% dextran sodium sulfate (DSS) for 6 days to induce ulcerative colitis-like disorder (UCLD). On day 6, mice were euthanized, and the colon was isolated to obtain immune cells incubated with antibodies to detect lymphocyte populations analyzed by flow cytometry. Representative dot plots for CD4<sup>+</sup> T lymphocytes <bold>(A)</bold>, CD8<sup>+</sup> T lymphocytes <bold>(B)</bold>, B lymphocytes <bold>(C)</bold>, Th17 lymphocytes <bold>(D)</bold>, and T<sub>reg</sub> lymphocytes <bold>(E)</bold> for each experimental group. The graphs with the percentage of CD4<sup>+</sup> T, CD8<sup>+</sup> T, B, Th17, and T<sub>reg</sub> lymphocytes are shown in <bold>(F&#x2013;J)</bold>, respectively. The values in the graphs are presented as mean &#xb1; S.E.M. Kruskal-Wallis and Dunn&#xb4;s post-test. Statistical significance is indicated as *<italic>p</italic> &#x2264; 0.05, *** <italic>p </italic>&lt; 0.001. <bold>(F)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 10. <bold>(G)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 9. <bold>(H)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 8, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 10. <bold>(I)</bold> Ctrl <italic>N</italic> = 4, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 7, and HTX+2%DSS <italic>N</italic> = 7. <bold>(J)</bold> Ctrl N=5, HTX N=7, Ctrl+2%DSS <italic>N</italic> = 10, and HTX+2%DSS <italic>N</italic> = 9.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>The levels of inflammatory and anti-inflammatory cytokines remained similar in the colon tissue of the HTX-offspring and Control-offspring with or without 6 days of UCLD induction</title>
<p>Cytokine secretion at the colon tissue can contribute to the development and intensity of UCLD (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>); therefore, the content of IL-17, IL-22, IFN-&#x3b3;, TNF-&#x3b1;, and IL-10 was measured by ELISA in the colon samples of all experimental groups (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). Not statistically significant differences were observed in any cytokine analyzed and between any experimental group.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Content of IL-17, IL-22, IFN-&#x3b3; TNF-&#x3b1; and IL-10 was similar between HTX- and Control-offspring. The HTX-offspring and Control-offspring were orally treated with 2% dextran sodium sulfate (DSS) for 6 days to induce ulcerative colitis-like disorder (UCLD). On day 6, mice were euthanized, and the colon was used to obtain a total protein sample for cytokine analysis by ELISA. The content was plotted in the following graphs: <bold>(A)</bold> IL-17, <bold>(B)</bold> IL-22, <bold>(C)</bold> IFN-&#x3b3;, <bold>(D)</bold> TNF-&#x3b1;, and <bold>(E)</bold> IL-10. No significant differences were observed between the experimental groups. <bold>(A)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 5. <bold>(B)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 5. <bold>(C)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 5, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 5. <bold>(D)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 5. <bold>(E)</bold> Ctrl <italic>N</italic> = 5, HTX <italic>N</italic> = 6, Ctrl+2%DSS <italic>N</italic> = 5, and HTX+2%DSS <italic>N</italic> = 5. The values in the graphs are presented as mean &#xb1; SEM (one-way ANOVA and Tukey&#x2019;s post-test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1269121-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This study shows evidence that male HTX-offspring develops earlier and increased pathological symptoms of UCLD compared with the male Control-offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). These data agree with previous findings showing that the HTX-offspring suffers early and strong symptoms of EAE (<xref ref-type="bibr" rid="B21">21</xref>). The fact that the DAI score of the HTX+T4-offspring was similar to the Control-offspring indicated that the earlier onset and intense symptoms of UCLD of the HTX-offspring are consequences of low T<sub>4</sub> during pregnancy and not due to other secondary effects of MMI treatment (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). The UCLD animal model used in this study can be considered as an acute model of UCLD given that the treatment with DSS was only for 6 days, and the analysis of inflammation on day 6 corresponds to the beginning of UC symptoms (<xref ref-type="bibr" rid="B33">33</xref>). The reason why we chose an acute model was based on our main question regarding whether gestational HTX can be a risk factor for increasing the susceptibility of earlier and strong immune-mediated diseases like UCLD. It has been documented that there is an association between UCLD pathological scores and colon tissue damage in the DSS model for UC-IBD (<xref ref-type="bibr" rid="B56">56</xref>). In this study, the HTX-offspring and Control-offspring treated with DSS presented scores of UCLD on day 3 and day 5 of DSS treatment, respectively. These UCLD pathological scores were confirmed by the histopathological analysis on day 6, by observing signs of tissue damage, such as distortion, erosion, cryptitis, and cellular infiltration at the proximal, middle, and distal colon in all experimental animal groups induced with UCLD. The histopathological analysis also reveals that both the Control-offspring and HTX-offspring without induction of UCLD have a histopathological score greater than zero and these were due to cell infiltration at the mucosa (see <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). The histopathological score significantly increased only at the proximal colon sections in the HTX-offspring induced with UCLD compared with the non-induced UCLD groups and the Control-offspring induced with UCLD (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). This result was unexpected given that it has been reported that the signs of damage in humans and mice suffering from UCLD start at the distal portion of the colon and continue ascending through the middle colon until the proximal region (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). In our results, the histopathological scores at the distal and middle portions of the colon were similar between the Control-offspring and HTX-offspring with UCLD (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>). However, the histopathological score at the proximal colon was significantly higher for the HTX-offspring induced with UCLD as compared with the Control-offspring induced with UCLD (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). These results suggest that the HTX-offspring could be more sensitive in developing inflammation, given that by inducing acute UCLD their proximal colon showed more damage compared with the proximal colon of the Control-offspring. In this work, we found evidence that the protective mechanisms at the colon can be impaired in the HTX-offspring. This is the case for <italic>MUC-2</italic> mRNA levels that were found significantly reduced in the HTX-offspring without UCLD induction as compared with the Control-offspring without UCLD induction (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). <italic>MUC-2</italic> encodes for a glycoprotein that is essential for the mucus to serve as the first barrier for protecting the intestinal epithelium from direct contact with the microbiota (<xref ref-type="bibr" rid="B29">29</xref>). Also, significantly lower levels of GCLC mRNA were found in the colon of the HTX-offspring with or without UCLD compared with the Control-offspring with or without UCLD, respectively (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). GCLC mRNA encodes for an antioxidant enzyme that protects the colon from tissue damage (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). The low levels of GCLC and MUC-2 mRNAs in the HTX-offspring support the notion that they could have a reduced capacity to protect the intestinal barrier against an insult. Moreover, the HTX-offspring induced with UCLD showed significantly lower levels of <italic>iNOS</italic> mRNA compared with the Control-offspring induced with UCLD (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>), suggesting that the HTX-offspring could have low levels of NO after acute UCLD induction (<xref ref-type="bibr" rid="B61">61</xref>). Several reports in the literature support that NO has a protective role at the beginning of UC and it becomes harmful at advanced stages of the disease (<xref ref-type="bibr" rid="B61">61</xref>&#x2013;<xref ref-type="bibr" rid="B63">63</xref>). Therefore, based on the pathological score of UCLD, we suggest that the low expression of <italic>iNOS</italic> in the HTX-offspring induced with acute UCLD would produce less NO. Low levels of NO in the HTX-offspring will leave the colon more sensitive to tissue damage. The levels of <italic>Lipocalin-2</italic> mRNA were higher in the HTX-offspring and Control-offspring induced with UCLD compared with the HTX-offspring and Control-offspring not induced with UCLD, respectively (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). A correlation matrix analysis showed that the content of Lipocalin-2 correlated with more intense UCLD (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5</bold>
</xref>). These results support that Lipocalin-2 secreted by macrophages, neutrophils, and parenchymal cells and its increased secretion during UC could serve as predictor markers of this disease (<xref ref-type="bibr" rid="B64">64</xref>).</p>
<p>The symptoms of UCLD started 3 days after DSS treatment in the HTX-offspring, which was significantly earlier as compared with 5 days for the Control-offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). These observations align with previous evidence that the HTX-offspring showed increased susceptibility to suffering enhanced EAE symptoms (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, these findings suggest that gestational HTX could imprint the progeny to be prone to exacerbation of immune and inflammatory responses. This notion is supported by the observations made with the HTX-offspring challenged with inflammatory disease models for EAE (<xref ref-type="bibr" rid="B21">21</xref>) or UCLD (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>), as well as after viral (<xref ref-type="bibr" rid="B22">22</xref>) or bacterial infections (<xref ref-type="bibr" rid="B8">8</xref>). In addition, offspring gestated in hypothyroidism and infected with <italic>Streptococcus pneumoniae</italic> developed stronger immune responses leading to protection against bacterial infection and dissemination, as well as increased host survival (<xref ref-type="bibr" rid="B8">8</xref>). Furthermore, although the HTX-offspring infected with the hMPV showed reduced viral loads, they displayed higher pathological scores due to an exacerbated immune response (<xref ref-type="bibr" rid="B22">22</xref>). We believe that the identification of the cellular and molecular mechanisms responsible for the immune system alterations observed in the HTX-offspring will contribute to molecular targets to further study the imprinting of this condition at the epigenetic level. Both innate and adaptive immune responses play important roles during autoimmune disease and infection (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B67">67</xref>). For that reason, in this study, myeloid and lymphoid cell populations resident in the colon were analyzed by flow cytometry (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>, respectively). It has been shown that Th1, Th17, and T<sub>reg</sub> lymphocytes are the primary T cells involved in UCLD. Therefore, Th17, CD4<sup>+</sup> T, CD8<sup>+</sup> T, T<sub>reg</sub>, and B lymphocyte cell populations were analyzed in the colon samples from all experimental mice (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). Even though we did not observe statistically significant differences in CD4<sup>+</sup> T and CD8<sup>+</sup> T lymphocytes between the HTX-offspring and the Control-offspring, there was a significant increase in the percentage of CD8<sup>+</sup> T lymphocytes for the HTX-offspring induced with UCLD compared with the HTX-offspring without UCLD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6G</bold>
</xref>). Consistent with this observation, children suffering from UC show higher numbers of CD8<sup>+</sup> T lymphocytes in their blood samples, which is associated with increased colon injury, such as ulcer formation (<xref ref-type="bibr" rid="B68">68</xref>). Therefore, it would be important to further study the contribution of CD8<sup>+</sup> T lymphocytes in the colon, blood, LMN, and spleen in the HTX-offspring and a possible association with increased UCLD pathological scores. Regarding T<sub>reg</sub> lymphocytes, no significant differences were observed between the HTX-offspring and the Control-offspring suffering from UCLD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6J</bold>
</xref>). However, T<sub>reg</sub> lymphocytes showed a significant increase in the HTX-offspring suffering from UCLD, as compared with those not treated with DSS (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6J</bold>
</xref>). This result was unexpected given that the percentage of T<sub>reg</sub> from the spleen did not change in the HTX-offspring induced with EAE (<xref ref-type="bibr" rid="B21">21</xref>). However, these cells showed reduced suppressive capacity as compared with T<italic>
<sub>reg</sub>
</italic> from the Control-offspring induced to develop EAE (<xref ref-type="bibr" rid="B21">21</xref>). Even though the percentage of T<sub>reg</sub> lymphocytes was higher in the colon of the HTX-offspring induced with UCLD, the content of IL-10 was similar among these groups (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>). The suppressive capacity of T<sub>reg</sub> from the spleen or colon was not analyzed in these experimental animal groups, and further studies should evaluate the functional capacity of these cells. Noteworthy was the observation that gestational HTX increases the percentage of Th17 lymphocyte population in their offspring with or without UCLD when they were compared with the Control-offspring with or without UCLD, respectively (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6I</bold>
</xref>). Thus, this result will suggest that the great number of Th17 lymphocytes in the HTX-offspring will contribute to the early onset and/or the high pathological score of UCLD, given that it has been reported that the immune response of Th17 lymphocytes is one of the principal pathological mechanisms involved in UC (<xref ref-type="bibr" rid="B69">69</xref>). Th17 cells in an inflammatory environment can increase the proportion of Th1 lymphocytes and the secretion of IFN-&#x3b3; by these cells, and probably by this mechanism, Th17 cells augment the intestinal injury and the disruption of the intestinal barrier in UC (<xref ref-type="bibr" rid="B70">70</xref>). This mechanism is unlikely to occur in the HTX-offspring given that the HTX-offspring with or without UCLD showed similar levels of IFN-&#x3b3; compared with the Control-offspring (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). Moreover, the content of IL-17 and IL-22 in the HTX-offspring induced with UCLD was similar to the Control-offspring induced with UCLD (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, B</bold>
</xref>, respectively). These results were unexpected given that there are more Th17 lymphocytes in the colon of the HTX-offspring than in the Control-offspring. A possible explanation for this observation is that Th17 cells from the HTX-offspring are not completely functional and secrete less IL-17 and IL-22. Under this scenario, we think that the HTX-offspring will need to augment the number of Th17 cells aiming to increase the production of these cytokines to protect the intestine. In fact, it has been shown that Th17 cells and these cytokines are important for a healthy homeostasis environment in the intestine to improve defense against extracellular pathogens by recruiting neutrophils and increasing intestinal barrier integrity (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Furthermore, that it has been described in the literature that Th17 lymphocytes can be anti-inflammatory or inflammatory and that the type of microbiota present at the intestinal lumen could play a role in the function of Th17 cells (<xref ref-type="bibr" rid="B72">72</xref>).</p>
<p>The HTX-offspring had a similar percentage of B lymphocytes in the colon (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6H</bold>
</xref>). It has been reported that UCLD induced by DSS increases the number of myeloid cells, such as DCs, neutrophils, monocytes, and macrophages (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). The percentage of neutrophils, monocytes, macrophages, and dendritic cells was similar in all experimental groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). It is possible that the low levels of DSS used in this study were insufficient to significantly increase the number of innate myeloid cells in the colon during UCLD induction (<xref ref-type="bibr" rid="B74">74</xref>). Meanwhile, the percentage of neutrophils in the HTX-offspring induced or not with UCLD was similar to the Control-offspring induced with UCLD (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). Thus, this study shows that the consequences of gestational HTX in the male offspring surpass the CNS, supporting that gestational HTX can predispose the male offspring to have accelerated and exacerbated UCLD symptoms. We believe that gestational HTX will also impact the symptomology of UCLD in females as it has been observed after EAE induction (<xref ref-type="bibr" rid="B21">21</xref>) and hMPV infection (<xref ref-type="bibr" rid="B22">22</xref>). Along these lines, it would be important to perform retrospective studies with human patients suffering from immune-mediated diseases, looking for an association with a possible HTX during pregnancy. These studies could contribute important information about whether gestational HTX in humans can be a risk factor for the offspring&#x2019;s predisposition to exacerbated detrimental inflammatory responses and immune-mediated diseases.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>In mice, gestational HTX impacted the onset and intensity of UCLD in the male offspring, suggesting that gestational HTX could be a potential risk factor for developing a more intense inflammatory disease like UC in humans. The reduced content of GCLC and MUC-2 mRNA and the high percentage of Th17 lymphocytes in the colon of the HTX-offspring can be part of the mechanisms altered in the HTX-offspring, making them more sensitive to an intense inflammatory disease. We emphasize the importance of elucidating the molecular mechanisms that have been affected in the HTX-offspring, aiming to uncover ways to revert or prevent the negative consequences of inflammatory diseases in this progeny.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors upon request to the corresponding author, without undue reservation. </p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Comit&#xe9; de &#xe9;tica Universidad Andr&#xe9;s Bello. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>JR: Investigation, Writing &#x2013; original draft. MO: Writing &#x2013; original draft, Conceptualization, Data curation, Writing &#x2013; review &amp; editing. RH: Writing &#x2013; original draft. OA: Writing &#x2013; original draft. MM: Writing &#x2013; original draft. EC: Writing &#x2013; original draft. SG: Data curation, Writing &#x2013; review &amp; editing. KB: Writing &#x2013; review &amp; editing. SB: Writing &#x2013; review &amp; editing. PG: Writing &#x2013; review &amp;&#xa0;editing. MN: Writing &#x2013; review &amp; editing. HB: Writing &#x2013; review &amp; editing. AK: Writing &#x2013; review &amp; editing. CR: Writing &#x2013; review &amp;&#xa0;editing, Conceptualization.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Millennium Institute on Immunology and Immunotherapy PROGRAMA ICM - ANID, ICN2021_045; FONDECYT #1191300, #1231905, #1231851, #1212075, and #11221280; FONDEF/IDeA ID20I10082, and PUENTE-2023-18. MM and EC thanks to ANID for providing a Ph.D. Scholarship [21211419 and 21202356, respectively]. </p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Mr. Luis M&#xe9;ndez for all his administrative and technical support in performing this work.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2023.1269121/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2023.1269121/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>MMI, 2-mercapto-1-methylimidazole or methimazole; T<sub>3</sub>, 3,5,3&#x2032;-L-tri-iodothyronine; T<sub>4</sub>, 3,5,3&#x2032;5&#x2032;-L-tetra-do-thyronine or thyroxine; CD, Crohn&#x2019;s disease; DSS, dextran sodium sulfate; EAE, experimental autoimmune encephalomyelitis; FBS, fetal bovine serum; GCLC, glutamate-cysteine ligase catalytic subunit; HBSS, Hank&#x2019;s balanced salt solution; HO-1, heme oxygenase 1; HTX, hypothyroxinemia; IBD, inflammatory bowel disease; MUC-2, mucin-2; NQO1, NADPH quinone oxidoreductase; PMA, phorbol myristate acetate; RPS6, ribosomal protein S6; TH, thyroid hormone; TSH, thyroid-stimulating hormone; DCs, dendritic cells; T<sub>reg</sub>, T regulatory; UCLD, ulcerative colitis-like disorder.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morreale de Escobar</surname> <given-names>G</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Escobar del Rey</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Role of thyroid hormone during early brain development</article-title>. <source>Eur J Endocrinol</source> (<year>2004</year>) <volume>151 Suppl</volume>:<page-range>U25&#x2013;37</page-range>. doi: <pub-id pub-id-type="doi">10.1530/eje.0.151u025</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vella</surname> <given-names>K</given-names>
</name>
<name>
<surname>Vella</surname> <given-names>S</given-names>
</name>
<name>
<surname>Savona-Ventura</surname> <given-names>C</given-names>
</name>
<name>
<surname>Vassallo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Thyroid dysfunction in pregnancy - a retrospective observational analysis of a Maltese cohort</article-title>. <source>BMC Pregnancy Childbirth</source> (<year>2022</year>) <volume>22</volume>:<fpage>941</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/S12884-022-05266-X</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis</article-title>. <source>J Endocrinol Invest</source> (<year>2022</year>), <page-range>1087&#x2013;101</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/S40618-022-01967-4</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dosiou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Medici</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns</article-title>. <source>Eur J Endocrinol</source> (<year>2017</year>) <volume>176</volume>:<page-range>R21&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/EJE-16-0354</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Meima</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Visser</surname> <given-names>WE</given-names>
</name>
</person-group>. <article-title>Thyroid hormone transporters in pregnancy and fetal development</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>:<elocation-id>15113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/IJMS232315113</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geno</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Nerenz</surname> <given-names>RD</given-names>
</name>
</person-group>. <article-title>Evaluating thyroid function in pregnant women</article-title>. (<year>2022</year>) <volume>59</volume>(<issue>7</issue>):<page-range>460&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408363.2022.2050182</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Flores</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Venegas</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Albornoz</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Cisternas</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation</article-title>. <source>Mol Neurobiol</source> (<year>2018</year>) <volume>55</volume>:<page-range>4373&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-017-0627-y</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieto</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Pe&#xf1;aloza</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Salazar-Echegarai</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Castellanos</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Venegas</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroidism improves the ability of the female offspring to clear streptococcus pneumoniae infection and to recover from pneumococcal pneumonia</article-title>. <source>Endocrinology</source> (<year>2016</year>) <volume>157</volume>:<page-range>2217&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2015-1957</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Haensgen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bohmwald</surname> <given-names>K</given-names>
</name>
<name>
<surname>Venegas</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Boudin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Elorza</surname> <given-names>AA</given-names>
</name>
<etal/>
</person-group>. <article-title>Imprinting of maternal thyroid hormones in the offspring</article-title>. <source>Int Rev Immunol</source> (<year>2017</year>) <volume>36</volume>:<page-range>240&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/08830185.2016.1277216</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albornoz</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Carre&#xf1;o</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Cortes</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Cisternas</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Cautivo</surname> <given-names>KM</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroidism increases the severity of experimental autoimmune encephalomyelitis in adult offspring</article-title>. <source>Thyroid</source> (<year>2013</year>) <volume>23</volume>:<page-range>1627&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2012.0401</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gianini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pancetti</surname> <given-names>F</given-names>
</name>
<name>
<surname>Azkcona</surname> <given-names>G</given-names>
</name>
<name>
<surname>Alarc&#xf3;n</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lizana</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring</article-title>. <source>Endocrinology</source> (<year>2008</year>) <volume>149</volume>:<page-range>5097&#x2013;106</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2008-0560</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuevas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Auso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Telefont</surname> <given-names>M</given-names>
</name>
<name>
<surname>Morreale de Escobar</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sotelo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Berbel</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence-derived neurons</article-title>. <source>Eur J Neurosci</source> (<year>2005</year>) <volume>22</volume>:<page-range>541&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04243.x</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavado-Autric</surname> <given-names>R</given-names>
</name>
<name>
<surname>Auso</surname> <given-names>E</given-names>
</name>
<name>
<surname>Garcia-Velasco</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Arufe Mdel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Escobar del Rey</surname> <given-names>F</given-names>
</name>
<name>
<surname>Berbel</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny</article-title>. <source>J Clin Invest</source> (<year>2003</year>) <volume>111</volume>:<page-range>1073&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI16262</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Association of gestational maternal hypothyroxinemia and increased autism risk</article-title>. <source>Ann Neurol</source> (<year>2014</year>) <volume>75</volume>:<page-range>971&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ana.24143</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gyllenberg</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sourander</surname> <given-names>A</given-names>
</name>
<name>
<surname>Surcel</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Hinkka-Yli-Salomaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>McKeague</surname> <given-names>IW</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>AS</given-names>
</name>
</person-group>. <article-title>Hypothyroxinemia during gestation and offspring schizophrenia in a national birth cohort</article-title>. <source>Biol Psychiatry</source> (<year>2016</year>) <volume>79</volume>:<page-range>962&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.06.014</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morreale de Escobar</surname> <given-names>G</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Escobar del Rey</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia</article-title>? <source>J Clin Endocrinol Metab</source> (<year>2000</year>) <volume>85</volume>:<page-range>3975&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.85.11.6961</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henrichs</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ghassabian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Tiemeier</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why</article-title>? <source>Clin Endocrinol (Oxf)</source> (<year>2013</year>) <volume>79</volume>:<page-range>152&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cen.12227</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghassabian</surname> <given-names>A</given-names>
</name>
<name>
<surname>El Marroun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Jaddoe</surname> <given-names>VW</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Verhulst</surname> <given-names>FC</given-names>
</name>
<etal/>
</person-group>. <article-title>Downstream effects of maternal hypothyroxinemia in early pregnancy: nonverbal IQ and brain morphology in school-age children</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2014</year>) <volume>99</volume>:<page-range>2383&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2013-4281</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korzeniewski</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Pinto-Martin</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Whitaker</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Feldman</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Lorenz</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>SE</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between transient hypothyroxinaemia of prematurity and adult autism spectrum disorder in a low-birthweight cohort: an exploratory study</article-title>. <source>Paediatr Perinat Epidemiol</source> (<year>2013</year>) <volume>27</volume>:<page-range>182&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ppe.12034</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gharagozloo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mace</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Calabresi</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis</article-title>. <source>Front Mol Neurosci</source> (<year>2022</year>) <volume>15</volume>:<elocation-id>995477</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FNMOL.2022.995477</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haensgen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Albornoz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Bugue&#xf1;o</surname> <given-names>K</given-names>
</name>
<name>
<surname>Jara Fern&#xe1;ndez</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Binzberger</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1257</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01257</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funes</surname> <given-names>SC</given-names>
</name>
<name>
<surname>R&#xed;os</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Fierro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rivera-P&#xe9;rez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Soto</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Valbuena</surname> <given-names>JR</given-names>
</name>
<etal/>
</person-group>. <article-title>Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8+ T lymphocytes</article-title>. <source>Front Immunol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>966917</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FIMMU.2022.966917</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Glutathione synthesis</article-title>. <source>Biochim Biophys Acta</source> (<year>2013</year>) <volume>1830</volume>:<page-range>3143&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.BBAGEN.2012.09.008</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebasti&#xe1;n</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Salazar</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Coronado-Arr&#xe1;zola</surname> <given-names>I</given-names>
</name>
<name>
<surname>Schultz</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Vallejos</surname> <given-names>OP</given-names>
</name>
<name>
<surname>Berkowitz</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Heme oxygenase-1 as a modulator of intestinal inflammation development and progression</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1956</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01956</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez-Fierro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Funes</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Rios</surname> <given-names>M</given-names>
</name>
<name>
<surname>Covi&#xe1;n</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Immune modulation by inhibitors of the ho system</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22010294</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riquelme</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Carre&#xf1;o</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Espinoza</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Mackern-Oberti</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Alvarez-Lobos</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of antigen processing by haem-oxygenase 1. Implications on inflammation and tolerance</article-title>. <source>Immunology</source> (<year>2016</year>) <volume>149</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12605</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funes</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Rios</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Fierro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Covi&#xe1;n</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bueno</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>1467</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01467</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preethi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Arthiga</surname> <given-names>K</given-names>
</name>
<name>
<surname>Patil</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Spandana</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway</article-title>. <source>Mol Biol Rep</source> (<year>2022</year>) <volume>49</volume>:<page-range>8907&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/S11033-022-07369-2</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bankole</surname> <given-names>E</given-names>
</name>
<name>
<surname>Read</surname> <given-names>E</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Garnett</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>The relationship between mucins and ulcerative colitis: A systematic review</article-title>. <source>J Clin Med</source> (<year>2021</year>) <volume>10</volume>:<elocation-id>1935</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/JCM10091935</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gajendran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Loganathan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jimenez</surname> <given-names>G</given-names>
</name>
<name>
<surname>Catinella</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>N</given-names>
</name>
<name>
<surname>Umapathy</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>A comprehensive review and update on ulcerative colitis</article-title>. <source>Dis Mon</source> (<year>2019</year>) <volume>65</volume>(<issue>12</issue>):<fpage>100851</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.DISAMONTH.2019.02.004</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agrawal</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sabino</surname> <given-names>J</given-names>
</name>
<name>
<surname>Frias-Gomes</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hillenbrand</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Soudant</surname> <given-names>C</given-names>
</name>
<name>
<surname>Axelrad</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses</article-title>. <source>EClinicalMedicine</source> (<year>2021</year>) <volume>36</volume>:<elocation-id>100884</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.ECLINM.2021.100884</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knauss</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gabel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Neurath</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Weigmann</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>The memory T cell &#x201c;Communication web&#x201d; in context with gastrointestinal disorders-how memory T cells affect their surroundings and how they are influenced by it</article-title>. <source>Cells</source> (<year>2022</year>) <volume>11</volume>(<issue>18</issue>):<fpage>2780</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/CELLS11182780</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultz</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Salazar</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Paduro</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Pardo-Roa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pizarro</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Salazar-Echegarai</surname> <given-names>FJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Persistent Salmonella enterica serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1166</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FIMMU.2018.01166</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Leary</surname> <given-names>S</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>CL</given-names>
</name>
</person-group>. <source>AVMA GUIDELINES FOR THE EUTHANASIA OF ANIMALS: 2020 EDITION AVMA Guidelines for the Euthanasia of Animals: 2020 Edition* Members of the Panel on Euthanasia AVMA Staff Consultants</source>. (<year>2020</year>).</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takagi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Naito</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mizushima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hirai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Harusato</surname> <given-names>A</given-names>
</name>
<name>
<surname>Okayama</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Heme oxygenase-1 prevents murine intestinal inflammation</article-title>. <source>J Clin Biochem Nutr</source> (<year>2018</year>) <volume>63</volume>:<page-range>169&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3164/JCBN.17-133</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chai</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>:<fpage>43126</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/SREP43126</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wirtz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Neufert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Weigmann</surname> <given-names>B</given-names>
</name>
<name>
<surname>Neurath</surname> <given-names>MF</given-names>
</name>
</person-group>. <article-title>Chemically induced mouse models of intestinal inflammation</article-title>. <source>Nat Protoc</source> (<year>2007</year>) <volume>2</volume>:<page-range>541&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/NPROT.2007.41</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erben</surname> <given-names>U</given-names>
</name>
<name>
<surname>Loddenkemper</surname> <given-names>C</given-names>
</name>
<name>
<surname>Doerfel</surname> <given-names>K</given-names>
</name>
<name>
<surname>Spieckermann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Haller</surname> <given-names>D</given-names>
</name>
<name>
<surname>Heimesaat</surname> <given-names>MM</given-names>
</name>
<etal/>
</person-group>. <article-title>A guide to histomorphological evaluation of intestinal inflammation in mouse models</article-title>. <source>Int J Clin Exp Pathol</source> (<year>2014</year>) <volume>7</volume>(<issue>8</issue>):<page-range>4557&#x2013;76</page-range>.</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chassaing</surname> <given-names>B</given-names>
</name>
<name>
<surname>Aitken</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Malleshappa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vijay-Kumar</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Dextran sulfate sodium (DSS)-induced colitis in mice</article-title>. <source>Curr Protoc Immunol</source> (<year>2014</year>) <volume>104</volume>:<page-range>15.25.1&#x2013;15.25.14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/0471142735.IM1525S104</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkowitz</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pardo-Roa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Salazar</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Salazar-Echegarai</surname> <given-names>F</given-names>
</name>
<name>
<surname>Miranda</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Ram&#xed;rez</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Mucosal exposure to cigarette components induces intestinal inflammation and alters antimicrobial response in mice</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>2289/FULL</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FIMMU.2019.02289/FULL</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo-Gonzalez</surname> <given-names>F</given-names>
</name>
<name>
<surname>Kammoun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Evren</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dutton</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Papadopoulou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bradford</surname> <given-names>BM</given-names>
</name>
<etal/>
</person-group>. <article-title>Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria</article-title>. <source>J Exp Med</source> (<year>2019</year>) <volume>216</volume>:<page-range>728&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/JEM.20180871</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLean</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Andrews</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hanson</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Baseler</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Anver</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Senkevitch</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-27 is a potential rescue therapy for acute severe colitis through interleukin-10-dependent, T-cell-independent attenuation of colonic mucosal innate immune responses</article-title>. <source>Inflammation Bowel Dis</source> (<year>2017</year>) <volume>23</volume>:<page-range>1983&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MIB.0000000000001274</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruf</surname> <given-names>J</given-names>
</name>
<name>
<surname>Carayon</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Structural and functional aspects of thyroid peroxidase</article-title>. <source>Arch Biochem Biophys</source> (<year>2006</year>) <volume>445</volume>:<page-range>269&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.ABB.2005.06.023</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cisternas</surname> <given-names>P</given-names>
</name>
<name>
<surname>Louveau</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bueno</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Boudin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Gestational hypothyroxinemia affects glutamatergic synaptic protein distribution and neuronal plasticity through neuron-astrocyte interplay</article-title>. <source>Mol Neurobiol</source> (<year>2016</year>) <volume>53</volume>:<page-range>7158&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-015-9609-0</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weller</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rozin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rigler</surname> <given-names>O</given-names>
</name>
<name>
<surname>Sack</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Neurobehavioral development of neonatal rats after <italic>in-utero</italic> hypothyroxinemia: efficacy of prenatal thyroxine treatment</article-title>. <source>Early Hum Dev</source> (<year>1996</year>) <volume>46</volume>:<fpage>63</fpage>&#x2013;<lpage>76</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0378-3782(96)01742-2</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pravda</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide</article-title>. <source>World J Gastroenterol</source> (<year>2022</year>) <volume>28</volume>:<page-range>4263&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/WJG.V28.I31.4263</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patlevi&#x10d;</surname> <given-names>P</given-names>
</name>
<name>
<surname>Va&#x161;kov&#xe1;</surname> <given-names>J</given-names>
</name>
<name>
<surname>&#x160;vorc</surname> <given-names>P</given-names>
</name>
<name>
<surname>Va&#x161;ko</surname> <given-names>L</given-names>
</name>
<name>
<surname>&#x160;vorc</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Reactive oxygen species and antioxidant defense in human gastrointestinal diseases</article-title>. <source>Integr Med Res</source> (<year>2016</year>) <volume>5</volume>:<page-range>250&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.IMR.2016.07.004</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenzel</surname> <given-names>UA</given-names>
</name>
<name>
<surname>Magnusson</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Rydstr&#xf6;m</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jonstrand</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hengst</surname> <given-names>J</given-names>
</name>
<name>
<surname>Johansson</surname> <given-names>MEV</given-names>
</name>
<etal/>
</person-group>. <article-title>Spontaneous colitis in muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<elocation-id>e100217</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0100217</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stallhofer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Friedrich</surname> <given-names>M</given-names>
</name>
<name>
<surname>Konrad-Zerna</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wetzke</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lohse</surname> <given-names>P</given-names>
</name>
<name>
<surname>Glas</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipocalin-2 is a disease activity marker in inflammatory bowel disease regulated by IL-17A, IL-22, and TNF-&#x3b1; and modulated by IL23R genotype status</article-title>. <source>Inflammation Bowel Dis</source> (<year>2015</year>) <volume>21</volume>:<page-range>2327&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MIB.0000000000000515</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chassaing</surname> <given-names>B</given-names>
</name>
<name>
<surname>Srinivasan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Delgado</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Young</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Gewirtz</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Vijay-Kumar</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation</article-title>. <source>PloS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e44328</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0044328</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gochman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mahajna</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shenzer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dahan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Blatt</surname> <given-names>A</given-names>
</name>
<name>
<surname>Elyakim</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans</article-title>. <source>Acta Histochem</source> (<year>2012</year>) <volume>114</volume>:<page-range>827&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.ACTHIS.2012.02.004</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krzystek-Korpacka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kempi&#x144;ski</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bromke</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Neubauer</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Oxidative stress markers in inflammatory bowel diseases: systematic review</article-title>. <source>Diagnostics</source> (<year>2020</year>) <volume>10</volume>(<issue>8</issue>):<fpage>601</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/DIAGNOSTICS10080601</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kofla-D&#x142;ubacz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pytrus</surname> <given-names>T</given-names>
</name>
<name>
<surname>Akutko</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sputa-Grzegrz&#xf3;&#x142;ka</surname> <given-names>P</given-names>
</name>
<name>
<surname>Piotrowska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dzi&#x119;giel</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Etiology of IBD-is it still a mystery</article-title>? <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>(<issue>20</issue>):<fpage>12445</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/IJMS232012445</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>YZ</given-names>
</name>
<name>
<surname>Li</surname> <given-names>YY</given-names>
</name>
</person-group>. <article-title>Inflammatory bowel disease: pathogenesis</article-title>. <source>World J Gastroenterol</source> (<year>2014</year>) <volume>20</volume>:<page-range>91&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/WJG.V20.I1.91</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eftychi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Schwarzer</surname> <given-names>R</given-names>
</name>
<name>
<surname>Vlantis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wachsmuth</surname> <given-names>L</given-names>
</name>
<name>
<surname>Basic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wagle</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Temporally distinct functions of the cytokines IL-12 and IL-23 drive chronic colon inflammation in response to intestinal barrier impairment</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>51</volume>:<fpage>367</fpage>&#x2013;<lpage>380.e4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.06.008</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fabian</surname> <given-names>O</given-names>
</name>
<name>
<surname>Bajer</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for</article-title>? <source>World J Gastroenterol</source> (<year>2022</year>) <volume>28</volume>:<elocation-id>5300</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/WJG.V28.I36.5300</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ungaro</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mehandru</surname> <given-names>S</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>PB</given-names>
</name>
<name>
<surname>Peyrin-Biroulet</surname> <given-names>L</given-names>
</name>
<name>
<surname>Colombel</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>Ulcerative colitis</article-title>. <source>Lancet</source> (<year>2017</year>) <volume>389</volume>:<page-range>1756&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(16)32126-2</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Siegmund</surname> <given-names>B</given-names>
</name>
<name>
<surname>Le Berre</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Ferrante</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Ulcerative colitis</article-title>. <source>Nat Rev Dis Primers</source> (<year>2020</year>) <volume>6</volume>(<issue>1</issue>):<fpage>74</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41572-020-0205-X</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corstjens</surname> <given-names>PLAM</given-names>
</name>
<name>
<surname>de Dood</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Priest</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Tanke</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Handali</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer</article-title>. <source>PloS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>:<elocation-id>2944</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/JOURNAL.PNTD.0002944</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Ayansola</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Quercetin alleviates intestinal oxidative damage induced by H2O2 via modulation of GSH: <italic>in vitro</italic> screening and in vivo evaluation in a colitis model of mice</article-title>. <source>ACS Omega</source> (<year>2020</year>) <volume>5</volume>:<page-range>8334&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/ACSOMEGA.0C00804/ASSET/IMAGES/LARGE/AO0C00804_0007.JPEG</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gantner</surname> <given-names>BN</given-names>
</name>
<name>
<surname>LaFond</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Bonini</surname> <given-names>MG</given-names>
</name>
</person-group>. <article-title>Nitric oxide in cellular adaptation and disease</article-title>. <source>Redox Biol</source> (<year>2020</year>) <volume>34</volume>:<elocation-id>101550</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.REDOX.2020.101550</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolios</surname> <given-names>G</given-names>
</name>
<name>
<surname>Valatas</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle</article-title>. <source>Immunology</source> (<year>2004</year>) <volume>113</volume>:<fpage>427</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/J.1365-2567.2004.01984.X</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krieglstein</surname> <given-names>CF</given-names>
</name>
<name>
<surname>Cerwinka</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Laroux</surname> <given-names>FS</given-names>
</name>
<name>
<surname>Salter</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Russell</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Schuermann</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide</article-title>. <source>J Exp Med</source> (<year>2001</year>) <volume>194</volume>:<page-range>1207&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/JEM.194.9.1207</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goetz</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Borregaard</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bluhm</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Raymond</surname> <given-names>KN</given-names>
</name>
<name>
<surname>Strong</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition</article-title>. <source>Mol Cell</source> (<year>2002</year>) <volume>10</volume>:<page-range>1033&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1097-2765(02)00708-6</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navegantes</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Souza Gomes</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>PAT</given-names>
</name>
<name>
<surname>Czaikoski</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Azevedo</surname> <given-names>CHM</given-names>
</name>
<name>
<surname>Monteiro</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity</article-title>. <source>J Trans Med</source> (<year>2017</year>) <volume>15</volume>:<fpage>1</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/S12967-017-1141-8</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soto</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Melo-Gonz&#xe1;lez</surname> <given-names>F</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Bueno</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Modulation of immune cells as a therapy for cutaneous lupus erythematosus</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>(<issue>18</issue>):<fpage>10706</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/IJMS231810706</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mora</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Loaiza</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Soto</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Bohmwald</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Involvement of trained immunity during autoimmune responses</article-title>. <source>J Autoimmun</source> (<year>2022</year>) <volume>137</volume>:<fpage>102956</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.JAUT.2022.102956</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabe</surname> <given-names>H</given-names>
</name>
<name>
<surname>Malmquist</surname> <given-names>M</given-names>
</name>
<name>
<surname>Barkman</surname> <given-names>C</given-names>
</name>
<name>
<surname>&#xd6;stman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gjertsson</surname> <given-names>I</given-names>
</name>
<name>
<surname>Saalman</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn&#x2019;s disease</article-title>. <source>Clin Exp Immunol</source> (<year>2019</year>) <volume>197</volume>:<page-range>111&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/CEI.13294</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imam</surname> <given-names>T</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Olson</surname> <given-names>MR</given-names>
</name>
</person-group>. <article-title>Effector T helper cell subsets in inflammatory bowel diseases</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1212</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FIMMU.2018.01212</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Elson</surname> <given-names>CO</given-names>
</name>
<name>
<surname>Fouser</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Kolls</surname> <given-names>JK</given-names>
</name>
</person-group>. <article-title>The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin</article-title>. <source>Annu Rev Pathol</source> (<year>2013</year>) <volume>8</volume>:<fpage>477</fpage>&#x2013;<lpage>512</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/ANNUREV-PATHOL-011110-130318</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jawale</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Biswas</surname> <given-names>PS</given-names>
</name>
<name>
<surname>McGeachy</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F</article-title>. <source>Cytokine</source> (<year>2021</year>) <volume>148</volume>:<elocation-id>155715</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.CYTO.2021.155715</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monteleone</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pallone</surname> <given-names>F</given-names>
</name>
<name>
<surname>Monteleone</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Th17-related cytokines: New players in the control of chronic intestinal inflammation</article-title>. <source>BMC Med</source> (<year>2011</year>) <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1741-7015-9-122/COMMENTS</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Bain</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Fenton</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>A</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Ivens</surname> <given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamics of colon monocyte and macrophage activation during colitis</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2764/FULL</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FIMMU.2018.02764/FULL</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>He</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity</article-title>. <source>Br J Pharmacol</source> (<year>2019</year>) <volume>176</volume>:<page-range>2209&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/BPH.14667</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>